Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: FTC final weight loss orders

This article was originally published in The Tan Sheet

Executive Summary

FTC final weight loss orders: Federal Trade Commission approves nine consent agreements with weight loss products marketers and their executives June 20. The agreements are with: Amerifit (Fat Burners and Fast Burners); KCD and Deerfield Corp. (SeQuester); Interactive Medical Technologies and Effective Health, Inc. (Lipitrol and SeQuester); 2943174 Canada (Svelt-Patch); Bodywell (Slimming Soles); Guildwood Direct Limited (Slimming Insoles); and Dean Distributors (Food for Life Weight Management System and Cambridge Diet). FTC has three separate consent orders with IMT/EHI and two company officers, William Pelzer and William Shell, MD. Under the orders, all of the companies are required to obtain additional scientific substantiation for their weight loss claims. The final orders contain the same provisions as FTC's proposed consent agreements with the firms, which were released March 25 in conjunction with a consumer education/regulatory program, "Operation Waistline" ("The Tan Sheet" March 31, pp. 9-11)...

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087207

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel